Inhibitory immune checkpoints in preeclampsia: current landscape, mechanisms, and clinical perspectives. [PDF]
Liu M +15 more
europepmc +1 more source
Triple-Negative Breast Cancer: Molecular Subtypes; Immune Escape; Limitations of Current Immunotherapy; and the BTLA/HVEM/CD160 Axis as an Emerging Target. [PDF]
Rapoport BL +6 more
europepmc +1 more source
Complete disruption of gD binding to HVEM alters virus replication and host receptor homeostasis. [PDF]
Arya D +4 more
europepmc +1 more source
Advances in Immune Checkpoint Inhibitors for Cancer Treatment. [PDF]
Chen K, Zhu F, Li X, Yoshimura T.
europepmc +1 more source
CD244 overexpression indicates NK cell dysfunction and tumor progression in diffuse large B-cell lymphoma. [PDF]
Yang Y +7 more
europepmc +1 more source
STC1 is associated with tumor progression and suppressive niches in laryngeal squamous cell carcinoma. [PDF]
Chen X +6 more
europepmc +1 more source
Immune checkpoint landscape in CD4⁺ T cells stratifies HIV-infected individuals by clinical progression. [PDF]
Spampinato S +4 more
europepmc +1 more source
A multi-omics integrative analyses reveals <i>CYBB</i>-mediated apoptotic and immune dysregulation as a key target of berberine in diffuse large B-cell lymphoma. [PDF]
Tan J +7 more
europepmc +1 more source
Efficacy and safety of venanprubart, a BTLA agonist antibody, in patients with active systemic lupus erythematosus. [PDF]
Ghosh I +8 more
europepmc +1 more source
Multiplex profiling of 16 immune checkpoints identifies novel serum biomarker panels for breast cancer detection and TNBC stratification: A case-control study. [PDF]
Stayoussef M +8 more
europepmc +1 more source

